DelMar Pharmaceuticals, Inc.
DelMar Pharmaceuticals, Inc. (DMPI) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 170 transactions totaling $759.8K, demonstrating a bullish sentiment with $551.8K in net insider flow. The most recent transaction on Jun 30, 2020 involved a transaction of 17 shares valued at $0.
DMPI Insider Activity Summary
Who Is Buying DMPI Stock?
No significant insider buying has been recorded for DMPI in the recent period.
Who Is Selling DMPI Stock?
No significant insider selling has been recorded for DMPI in the recent period.
Is DelMar Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for DMPI is bullish with an Insider Alignment Score of 86/100 and a net flow of $551.8K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
DMPI Frequently Asked Questions
Understanding DMPI Insider Activity
Insider trading at DelMar Pharmaceuticals, Inc. (DMPI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading DMPI stock, having executed 170 transactions in the past 90 days. The most active insider is Dennis M. Brown (Executive), who has made 26 transactions totaling $355.7K.
Related Tools
Track DelMar Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at DMPI file new Form 4 transactions